NCT00080327View on ClinicalTrials.gov

Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia

PHASE4CompletedINTERVENTIONAL
Enrollment

370

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

September 30, 2004

Study Completion Date

September 30, 2004

Conditions
Schizophrenia
Interventions
DRUG

Aripiprazole

Tablets, Oral, 2mg, Once daily, 6 weeks.

DRUG

Aripiprazole

Tablets, Oral, 5mg, Once daily, 6 weeks.

DRUG

Aripiprazole

Tablets, Oral, 10mg, Once daily, 6 weeks.

DRUG

Placebo

Tablets, Oral, 0mg, Once daily, 6 weeks.

Trial Locations (1)

Unknown

Bristol-Meyers Squibb Call Center, Wallingford

Sponsors
All Listed Sponsors
collaborator

Otsuka America Pharmaceutical

INDUSTRY

lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY